Controlled Quercetin Release by Fluorescent Mesoporous Nanocarriers for Effective Anti-Adipogenesis

Autor: Kim T, Cho AY, Lee SW, Lee HJ
Jazyk: angličtina
Rok vydání: 2024
Předmět:
Zdroj: International Journal of Nanomedicine, Vol Volume 19, Pp 5441-5458 (2024)
Druh dokumentu: article
ISSN: 1178-2013
Popis: Taelin Kim,* A Yeon Cho,* Sang-Wha Lee, Hyun Jong Lee School of Chemical, Biological and Battery Engineering, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea*These authors contributed equally to this workCorrespondence: Sang-Wha Lee; Hyun Jong Lee, School of Chemical, Biological and Battery Engineering, Gachon University, Seongnam-si, Gyeonggi-do, Republic of Korea, Email lswha@gachon.ac.kr; hjlee2@gachon.ac.krIntroduction: Quercetin (QUER), a flavonoid abundant in fruits and vegetables, is emerging as a promising alternative therapeutic agent for obesity treatment due to its antioxidant and anti-adipogenic properties. However, the clinical application of QUER is limited by its poor solubility, low bioavailability, and potential toxicity at high doses. To address these challenges, this study aims to develop an advanced drug delivery system using fluorescent mesoporous silica nanoparticles (FMSNs) coated with polydopamine (PDA) for the efficient and sustained delivery of QUER to inhibit adipogenesis.Methods: The research included the synthesis of PDA-coated FMSNs for encapsulation of QUER, characterization of their mesoporous structures, and systematic investigation of the release behavior of QUER. The DPPH assay was used to evaluate the sustained radical scavenging potential. Concentration-dependent effects on 3T3-L1 cell proliferation, cellular uptake and adipogenesis inhibition were investigated.Results: PDA-coated FMSNs exhibited well-aligned mesoporous structures. The DPPH assay confirmed the sustained radical scavenging potential, with FMSNs-QUER@PDA showing 53.92 ± 3.48% inhibition at 72 h, which was higher than FMSNs-QUER (44.66 ± 0.57%) and free QUER (43.37 ± 5.04%). Concentration-dependent effects on 3T3-L1 cells highlighted the enhanced efficacy of PDA-coated FMSNs for cellular uptake, with a 1.5-fold increase compared to uncoated FMSNs. Adipogenesis inhibition was also improved, with relative lipid accumulation of 44.6 ± 4.6%, 37.3 ± 4.6%, and 36.5 ± 7.3% at 2.5, 5, and 10 μM QUER concentrations, respectively.Conclusion: The study successfully developed a tailored drug delivery system, emphasizing sustained QUER release and enhanced therapeutic effects. FMSNs, especially when coated with PDA, exhibit promising properties for efficient QUER delivery, providing a comprehensive approach that integrates advanced drug delivery technology and therapeutic efficacy. Keywords: mesoporous silica nanoparticles, quercetin, polydopamine coating, drug delivery system, adipogenesis inhibition, sustained release
Databáze: Directory of Open Access Journals